½ÃÀ庸°í¼­
»óǰÄÚµå
1570639

À¯·´ÀÇ µðÁöÅÐ Áø´Ü ½ÃÀå : ¿ëµµº°, Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º° - ºÐ¼®°ú ¿¹Ãø(2023-2033³â)

Europe Digital Diagnostics Market: Focus on Application, Product, End User, and Country - Analysis and Forecast, 2023-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BIS Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 1-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À¯·´ÀÇ µðÁöÅÐ Áø´Ü ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 2,520¸¸ ´Þ·¯¿¡¼­ 2033³â¿¡´Â 25¾ï 3,820¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2033³âÀÇ CAGRÀº 19.56¿¡ ´ÞÇÒ °ÍÀ¸·Î º¸À̰í ÀÖ½À´Ï´Ù.

À¯·´ÀÇ µðÁöÅÐ Áø´Ü ½ÃÀåÀº ±âÁ¸ ±â¾÷°ú ½Å±Ô ±â¾÷ÀÌ ½ÃÀå ÆÐ±ÇÀ» ³õ°í Ä¡¿­ÇÑ °æÀïÀ» ¹úÀ̰í ÀÖ½À´Ï´Ù. ÀÌ »ê¾÷ÀÇ ¿¹»ó ¼ºÀå ±âȸ¿Í ÁøÈ­´Â °úÁ¦¿Í ±âȸ¸¦ °¡Á®´ÙÁÖ¸ç, ÇâÈÄ ÁÖ¸ñÇØ¾ß ÇÒ ¸Å·ÂÀûÀÎ ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Áø´Ü »ê¾÷ÀÌ ¼ºÀåÇÔ¿¡ µû¶ó ±â¾÷Àº µ¥ÀÌÅÍ º¸¾È, ½ÃÀå Æ÷È­, ±ÔÁ¦ Áؼö µîÀÇ ¹®Á¦¿¡ Á÷¸éÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª º¯È­ÇÏ´Â °í°´ÀÇ ±â´ë¿¡ ºÎÀÀÇϰí, Àü·«Àû Á¦ÈÞ¸¦ ±¸ÃàÇϰí, »õ·Î¿î ±â¼úÀ» ºü¸£°Ô µµÀÔÇÒ ¼ö ÀÖ´Â ÀÎÀç¿¡°Ô´Â ¸¹Àº ±âȸ°¡ ÀÖ½À´Ï´Ù.

½ÃÀå ¼­·Ð

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2023-2033³â
2023³âÀÇ Æò°¡ 4¾ï 2,520¸¸ ´Þ·¯
2033³â ¿¹Ãø 25¾ï 3,820¸¸ ´Þ·¯
CAGR 19.56%

À¯·´ÀÇ µðÁöÅÐ Áø´Ü ½ÃÀåÀº È¿°úÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸ÀÇ Áõ°¡¿Í ±â¼ú Çâ»ó ¾çÃø¿¡ ÀÇÇØ Å©°Ô È®´ëÇϰí ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·áÀÇ º¸±Þ, Áø´Ü¿¡¼­ AI¿Í ±â°èÇнÀÀÇ È°¿ë, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñÀÇ Áõ°¡´Â ÀÌ·¯ÇÑ È®ÀåÀÇ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ½Ç½Ã°£ µ¥ÀÌÅÍ¿Í ºÐ¼®À» ÅëÇØ ±âÁ¸ Áø´Ü ÀýÂ÷¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖÀ¸¸ç, ÀÇ·áÁøµéÀÌ ´õ ¸¹Àº Á¤º¸¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ COVID-19 ÆÒµ¥¹ÍÀº µðÁöÅÐ Áø´ÜÀ¸·ÎÀÇ ÀüȯÀ» ÃËÁøÇϰí, ½Å¼ÓÇÏ°í ¿ø°ÝÀ¸·Î °Ë»çÇÒ ¼ö ÀÖ´Â ¿É¼ÇÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. À¯·´ ±ÔÁ¦ ´ç±¹Àº µðÁöÅÐ Áø´Ü ÅøÀ» ½ÂÀÎÇϰí ÀÇ·á ½Ã½ºÅÛ¿¡ ½±°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â ÇÁ·¹ÀÓ¿öÅ©¸¦ ¸¶·ÃÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ÀüȯÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ µðÁöÅÐ Áø´Ü ½ÃÀåÀº ¿ø°Ý ¸ð´ÏÅ͸µ ¹× Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ´Â ÇコÄÉ¾î »ê¾÷ÀÇ º¯È­ÇÏ´Â ¿ä±¸¿¡ ÀûÀÀÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ±â¾÷¿¡°Ô »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

À¯·´ÀÇ µðÁöÅÐ Áø´Ü ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í ¿ëµµº°, Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

°³¿ä

Á¦1Àå ½ÃÀå

  • µ¿Çâ : ÇöÀç ¹× ÇâÈÄ ¿µÇâ Æò°¡
  • ¿¬±¸°³¹ß ¸®ºä
  • ±ÔÁ¦ »óȲ
  • ÁÖ¿ä ¼¼°è À̺¥Æ®ÀÇ ¿µÇ⠺м® - COVID-19
  • ½ÃÀå ¿ªÇÐ : °³¿ä

Á¦2Àå Áö¿ª

  • Áö¿ªº° °³¿ä
  • ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
  • À¯·´

Á¦3Àå ½ÃÀå - °æÀï º¥Ä¡¸¶Å·°ú

±â¾÷ °³¿ä

  • Áö¿ªÀû Æò°¡
    • Koninklijke Philips N.V.
    • Siemens Healthineers
    • Medtronic plc
    • Nano-X Imaging Ltd.
    • Brainomix

Á¦4Àå Á¶»ç ¹æ¹ý

KSA 24.10.24

Introduction to Europe Digital Diagnostics Market

The Europe digital diagnostics market is projected to reach $2,538.2 million by 2033 from $425.2 million in 2023, growing at a CAGR of 19.56% during the forecast period 2023-2033. The European digital diagnostics market is typified by high rivalry, with both established enterprises and emerging players striving for market dominance. The predicted growth and evolution of this industry bring challenges and opportunities, making it a fascinating area to watch in the future years. Businesses will encounter challenges with data security, market saturation, and regulatory compliance as the digital diagnostics industry grows. But there are lots of chances for people who can fulfill changing client expectations, create strategic alliances, and quickly adopt new technologies.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$425.2 Million
2033 Forecast$2,538.2 Million
CAGR19.56%

The market for digital diagnostics in Europe is expanding significantly due to both the growing need for effective healthcare solutions and technological improvements.

The spread of telemedicine, the use of AI and machine learning in diagnostics, and the increased focus on personalized care are important drivers of this expansion. With the use of real-time data and analytics, these innovations are revolutionizing traditional diagnostic procedures and empowering medical practitioners to make more informed judgments.

Furthermore, the pandemic of COVID-19 has expedited the transition to digital diagnostics, emphasizing the necessity for quick and remote testing options. European regulatory agencies are also aiding with this shift by putting in place frameworks that make it easier to approve and incorporate digital diagnostic tools into healthcare systems.

The European digital diagnostics market is expected to grow significantly due to the increasing demand for remote monitoring and diagnostic solutions. This will present new opportunities for innovative firms that can adjust to the evolving needs of the healthcare industry.

Market Segmentation:

Segmentation 1: by Application

  • Cardiology
  • Oncology
  • Neurology
  • Pathology
  • Others

Segmentation 2: by End User

  • Hospitals
  • Clinical Laboratories
  • Others

Segmentation 3: by Product

  • Hardware
  • Software

Segmentation 4: by Country

  • Germany
  • France
  • Italy
  • Spain
  • U.K.
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe digital diagnostics market (by application) has been segmented into detailed segments of the application of digital diagnostics based on disease indications, including cardiology, oncology, neurology, pathology, and others. Moreover, the study provides the reader with a detailed understanding of the products that are majorly segmented into hardware and software.

Growth/Marketing Strategy: The digital diagnostics market encompasses a range of digital devices available in the market. Since the market is growing, there are upcoming technologies that can further enhance the adoption of digital diagnostics and AI in the market.

Competitive Strategy: Key players in the Europe digital diagnostics market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe digital diagnostics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Digital Diagnostics Market Trend Analysis
    • 1.1.2 Increasing Number of Startups in the Market
    • 1.1.3 Partnerships and Collaborations among Market Players
  • 1.2 Research and Development Review
    • 1.2.1 Patent Filing Trend (by Country, Year)
  • 1.3 Regulatory Landscape
  • 1.4 Impact Analysis for Key Global Events - COVID-19
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Growing Burden of Chronic Diseases
      • 1.5.1.2 Increasing Adoption of Advanced Technologies
      • 1.5.1.3 AI Adoption in Digital Diagnostic Devices
    • 1.5.2 Market Restraints
      • 1.5.2.1 Challenges Regarding Biased Data Leading to Miscalculations in Data-Driven Diagnostic Software
      • 1.5.2.2 Lack of Stringent Regulatory Guidelines
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Increasing Opportunities for Digital Diagnostic Solutions in Emerging Economies
      • 1.5.3.2 Synergetic Partnership Opportunities with Hospitals and Diagnostic Centers to Reduce Wait Times and Burden

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
      • 2.3.1.1 Driving Factors for Market Growth
      • 2.3.1.2 Factors Challenging the Market
    • 2.3.2 Application
    • 2.3.3 Product
    • 2.3.4 France
    • 2.3.5 Germany
    • 2.3.6 U.K.
    • 2.3.7 Spain
    • 2.3.8 Italy
    • 2.3.9 Rest-of-Europe

3 Markets -Competitive Benchmarking &

Company Profiles

  • 3.1 Geographic Assessment
    • 3.1.1 Koninklijke Philips N.V.
      • 3.1.1.1 Overview
      • 3.1.1.2 Top Products/Product Portfolio
      • 3.1.1.3 Target Customers
      • 3.1.1.4 Key Personnel
      • 3.1.1.5 Analyst View
    • 3.1.2 Siemens Healthineers
      • 3.1.2.1 Overview
      • 3.1.2.2 Top Products/Product Portfolio
      • 3.1.2.3 Target Customers
      • 3.1.2.4 Key Personnel
      • 3.1.2.5 Analyst View
    • 3.1.3 Medtronic plc
      • 3.1.3.1 Overview
      • 3.1.3.2 Top Products
      • 3.1.3.3 Target Customers
      • 3.1.3.4 Key Personnel
      • 3.1.3.5 Analyst View
    • 3.1.4 Nano-X Imaging Ltd.
      • 3.1.4.1 Overview
      • 3.1.4.2 Top Products
      • 3.1.4.3 Target Customers
      • 3.1.4.4 Key Personnel
      • 3.1.4.5 Analyst View
    • 3.1.5 Brainomix
      • 3.1.5.1 Overview
      • 3.1.5.2 Top Products
      • 3.1.5.3 Target Customers
      • 3.1.5.4 Key Personnel
      • 3.1.5.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦